Skip to main content

Early Childhood Development

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Infant Behavior ProgramN/A1 trial
Active Trials
NCT04594902Active Not Recruiting288Est. Sep 2026
Relief Therapeutics
Relief TherapeuticsSwitzerland - Geneva
1 program
Integrated Mothers and Babies CourseN/A1 trial
Active Trials
NCT03665246Completed378Est. Feb 2020
Bracco
BraccoItaly - Milan
1 program
Integrated child stimulation, nutrition, lead, arsenic, WASH interventionN/A1 trial
Active Trials
NCT04111016CompletedEst. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesInfant Behavior Program
BraccoIntegrated child stimulation, nutrition, lead, arsenic, WASH intervention
Relief TherapeuticsIntegrated Mothers and Babies Course

Clinical Trials (3)

Total enrollment: 666 patients across 3 trials

NCT04594902Human BioSciencesInfant Behavior Program

The PANTHERS (Parents and iNfants Together in Home-based Early Remote Services) Project

Start: Mar 2021Est. completion: Sep 2026288 patients
N/AActive Not Recruiting
NCT04111016BraccoIntegrated child stimulation, nutrition, lead, arsenic, WASH intervention

Feasibility of Implementing RINEW Through the Government System

Start: Apr 2019Est. completion: Sep 2020
N/ACompleted
NCT03665246Relief TherapeuticsIntegrated Mothers and Babies Course

Evaluation of the iMBC/ECD Model in Ghana

Start: Aug 2018Est. completion: Feb 2020378 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.